PYXS

Pyxis Oncology, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Connealy Pamela AnnCFO & COO
$11k5.5k shares
BuyNov 26, 2024
$2.00
--
Connealy Pamela AnnCFO & COO
$163k83.4k shares
BuyNov 26, 2024
$1.96
--
Humphrey RachelDirector
$14k13.9k shares
SellApr 21, 2025
$1.03
--
Humphrey RachelDirector
$194200 shares
SellApr 17, 2025
$0.97
--
Humphrey RachelDirector
$1.4k1.4k shares
SellApr 14, 2025
$0.9727
--

News

globenewswire.comPyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestonesglobenewswire.comMay 14globenewswire.comPyxis Oncology to Participate in Upcoming Investor Conferencesglobenewswire.comMay 13globenewswire.comPyxis Oncology Appoints Nelson Azoulay as Chief Business Officerglobenewswire.comMay 7globenewswire.comPyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026globenewswire.comApr 17globenewswire.comPyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Resultsglobenewswire.comMar 23